Centaurus Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.2M | Sell |
13,110
-616
| -4% | -$480K | 0.6% | 38 |
|
2025
Q1 | $11.3M | Sell |
13,726
-712
| -5% | -$588K | 0.69% | 38 |
|
2024
Q4 | $11.1M | Buy |
14,438
+2,975
| +26% | +$2.3M | 0.68% | 35 |
|
2024
Q3 | $10.2M | Buy |
11,463
+5,364
| +88% | +$4.75M | 0.65% | 37 |
|
2024
Q2 | $5.52M | Buy |
6,099
+3,085
| +102% | +$2.79M | 0.37% | 62 |
|
2024
Q1 | $2.35M | Buy |
3,014
+1,011
| +50% | +$787K | 0.16% | 135 |
|
2023
Q4 | $1.17M | Buy |
2,003
+35
| +2% | +$20.4K | 0.09% | 218 |
|
2023
Q3 | $1.06M | Sell |
1,968
-685
| -26% | -$368K | 0.09% | 221 |
|
2023
Q2 | $1.24M | Sell |
2,653
-1,568
| -37% | -$735K | 0.11% | 197 |
|
2023
Q1 | $1.45M | Sell |
4,221
-599
| -12% | -$206K | 0.12% | 198 |
|
2022
Q4 | $1.76M | Buy |
4,820
+948
| +24% | +$347K | 0.17% | 148 |
|
2022
Q3 | $1.25M | Buy |
3,872
+464
| +14% | +$150K | 0.12% | 198 |
|
2022
Q2 | $1.11M | Buy |
3,408
+1,092
| +47% | +$354K | 0.11% | 220 |
|
2022
Q1 | $663K | Sell |
2,316
-8
| -0.3% | -$2.29K | 0.05% | 354 |
|
2021
Q4 | $642K | Buy |
2,324
+343
| +17% | +$94.8K | 0.05% | 381 |
|
2021
Q3 | $458K | Buy |
+1,981
| New | +$458K | 0.04% | 439 |
|
2021
Q2 | – | Sell |
-616
| Closed | -$115K | – | 915 |
|
2021
Q1 | $115K | Buy |
+616
| New | +$115K | 0.01% | 751 |
|
2018
Q3 | – | Sell |
-6,214
| Closed | -$530K | – | 1386 |
|
2018
Q2 | $530K | Buy |
6,214
+3,159
| +103% | +$269K | 0.07% | 291 |
|
2018
Q1 | $236K | Buy |
+3,055
| New | +$236K | 0.06% | 299 |
|